A total of 1573 women responded to the follow-up questionnaire, of which > 80% reported that their urinary incontinence symptoms were bothersome. The greatest negative effect appeared to be on physical activities, confidence, self-perception and social activities, with a statistically significant correlation between an increase in bothersomeness and an increase in severity of symptoms. Similarly, a negative impact on QoL was associated with an increase in severity of incontinence. The variables: country, urinary incontinence type, severity, age, number of medical conditions and number of leakages had a statistically significant influence on the bother and the validated incontinence QoL (I-QoL) questionnaire scores.
CONCLUSIONThe extent to which women are bothered by their urinary incontinence and report that their symptoms have a negative impact on their QoL is largely subjective. In determining the most appropriate management, physicians should consider the experience of being incontinent as unique to each individual.
KEYWORDS urinary incontinence, type of incontinence, quality of life, bothersomeness
OBJECTIVETo assess the bothersomeness and impact on quality of life (QoL) of urinary incontinence in community-dwelling women in France, Germany, Spain and the UK.
SUBJECTS AND METHODSA detailed follow-up questionnaire was mailed to 2960 randomly-selected women who had reported symptoms of urinary incontinence in an earlier survey of 29 500 representative households in four European countries. In the second questionnaire, women were asked about the severity of their symptoms, the impact of urinary incontinence on their QoL, and how bothersome their incontinence was.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.